# HMPL-A830 in Solid Tumors

> **NCT07718581** · PHASE1,PHASE2 · RECRUITING · sponsor: **Hutchmed** · enrollment: 147 (estimated)

## Conditions studied

- Solid Tumor, Adult

## Interventions

- **DRUG:** HMPL-A830
- **DRUG:** HMPL-A830

## Key facts

- **NCT ID:** NCT07718581
- **Lead sponsor:** Hutchmed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-24
- **Primary completion:** 2029-05-23
- **Final completion:** 2029-12-15
- **Target enrollment:** 147 (ESTIMATED)
- **Last updated:** 2026-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07718581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07718581, "HMPL-A830 in Solid Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07718581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*